We integrate cutting-edge technologies, end-to-end capabilities, and the smartest people to regenerate cells, rewrite genes, and redefine manufacturing, right from the start.
// About ElevateBio
A New Approach to Cell and Gene Therapy Development
We are a technology-driven cell and gene therapy company, accelerating access to the cutting-edge technologies and expertise that will change the future of medicine.
Our integrated model, combining R&D platforms and cGMP manufacturing, unifies groundbreaking technologies forging the missing link between discovery and widespread delivery of cell and gene therapies as everyday medicine. Our ecosystem enhances speed, delivery, and probability of success to change patient lives.
Separately, the individual components are powerful – together, they are catalytic.
BaseCamp® is our genetic medicine cGMP manufacturing and process development business that offers end-to-end capabilities for cell and gene therapies and regenerative medicines for our partners and our programs.
Our integrated technologies and full-scale capacity available at BaseCamp provide our scientists and partners with turnkey and scalable access to the critical technologies and services they need, when they need them.
We have multiple technology platforms:
- Life Edit, a novel, full-spectrum gene-editing platform available to make the entire spectrum of edits, from small insertions or deletions to rewriting DNA sequences
- Induced pluripotent stem cell (iPSC) platform pioneering and accelerating the development of cell therapies and regenerative medicines leveraging our next-generation cell lines
- RNA, Cell, protein, and vector engineering to enable the construction and scaling of cell and gene therapies
With these proprietary technologies and the ability to combine them, we can accelerate the development of a range of therapies for our partners and our internal pipeline.
Our integrated platforms model is creating significant value. We can speed advancement of the underlying science, development, and manufacturing of the cell and gene therapies, while simultaneously propelling our own innovative pipeline in cellular, genetic and regenerative medicine.
- Internal therapeutics: With these leading-edge platforms, we are building a highly innovative pipeline of in vivo and ex vivo therapeutics driven by our Research & Development organization.
- Partnered therapeutics: Our integrated technologies model offers turnkey scale and biotechnological capabilities to power cell and gene therapy processes, programs, and companies to their full potential.
Partner with ElevateBio®
Wherever you are in your cell and gene therapy product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.
// Work with us